Cue Biopharma reports 2022 annual meeting voting results

Cue Biopharma, Inc.

All seven director nominees elected (Driscoll, Fletcher, Gray, Howson, Kiener, Morich, Passeri).
Ratification of RSM US LLP as independent auditor for FY 2022 approved with 26,125,468 votes for.
Broker non-votes of 14,293,960 on director elections; no other proposals were voted on.
Meeting held June 9, 2022; results filed on June 10, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.